Among these, VIPR1 has been identified as a protective gene for the survival of NSCLC patients, whereas NEK2, HMGA1, FERMT1, SLC7A5, and TNS4 are risk genes. The gene discussed is TNS4; the disease is non-small cell lung carcinoma.